TYRONIESHA REED: Open Payments
NPI 1679263578 · FARGO, ND. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,377 in 25 payments from 10 companies in 2025. Trend: 2023 $99 · 2024 $562 · 2025 $1,377
Travel & lodging: $770Food & beverage: $606
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 13 | $1,118 |
| Teva Pharmaceuticals USA, Inc. | 3 | $73 |
| Biogen, Inc. | 1 | $40 |
| Lundbeck LLC | 2 | $35 |
| GENZYME CORPORATION | 1 | $28 |
| ABBVIE INC. | 1 | $18 |
| Invivyd Inc | 1 | $18 |
| Merz Pharmaceuticals, LLC | 1 | $17 |
| Neurocrine BioSciences, Inc. | 1 | $15 |
| Amneal Pharmaceuticals LLC | 1 | $15 |
Products named: INFINITY, AUSTEDO XR, VYEPTI, FABRAZYME, AJOVY, QULIPTA, PEMGARDA, Xeomin.
Industry payments across ND — which companies pay providers there.
